SPINK1 and hepatocellular carcinoma: To probe into the roles of SPINK1 in systematic HCC treatments, we introduced a ST dataset (cohort 5, Supplementary Table S1) collected from HCC patients treated with neoadjuvant cabozantinib and nivolumab [21].